Literature DB >> 8786380

Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis.

C Ikonomidou1, Y Qin Qin, J Labruyere, J W Olney.   

Abstract

A superoxide dismutase 1 (SOD-1)genetic defect has been identified in familial amyotrophic lateral sclerosis (ALS) and motor neuron degeneration has been described in SOD-1 transgenic mice. Because an excitotoxic mechanism has been implicated in ALS, we undertook studies to provide a description of excitotoxic degeneration of spinal motor neurons for comparison with the degenerative process observed in SOD-1 transgenic mice. Excitotoxin agonists selective for each of the three major types of inotropic glutamate receptors were applied directly onto the lumbar spinal cord of 21-day old rats following posterior laminectomy. N-methyl-D-aspartate (NMDA) preferentially affected dorsal horn neurons, whereas the non-NMDA agonist, kainic acid, preferentially affected motor neurons. Cytopathological changes in motor neurons closely resembled those described in SOD-1 mice. These changes consist of massively swollen dendritic processes in the presence of well-preserved presynaptic axon terminals; cell bodies of motor neurons filled with vacuoles that originate both from endoplasmic reticulum and mitochondria; pleomorphic changes in mitochondria; axons of motor neuron becoming swollen proximally with accumulation of vacuoles, organelles, filaments, and degeneration products in the swollen segment. The observed changes in motor axons resemble changes described in the spinal cord of ALS patients. These findings are consistent with the proposal that motor neuron degeneration in ALS may be mediated by an excitotoxic process involving hyperactivation with non-NMDA glutamate receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786380     DOI: 10.1097/00005072-199602000-00010

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

1.  AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability.

Authors:  W Vandenberghe; E C Ihle; D K Patneau; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

2.  Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Liqing Luo; G R Wayne Moore; Donald W Paty; Max S Cynader
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability.

Authors:  W Vandenberghe; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway.

Authors:  Meihui Chen; Min Tan; Minghua Jing; Anmin Liu; Qinyu Liu; Shijun Wen; Ziwei Chen; Xiaojuan Chao; Xixin He; Charles Ramassamy; Youheng Gao; Rongbiao Pi
Journal:  Metab Brain Dis       Date:  2014-07-23       Impact factor: 3.584

Review 5.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

Review 6.  Treatment of amyotrophic lateral sclerosis--what is the next step?

Authors:  A C Ludolph
Journal:  J Neurol       Date:  2000-12       Impact factor: 4.849

Review 7.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

8.  Effects of NMDA and its antagonists on ventral horn cholinergic neurons in organotypic roller tube spinal cord cultures.

Authors:  J R Delfs; D M Saroff; Y Nishida; J Friend; C Geula
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 9.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.